Skip to content
Menu

Canaccord Genuity Maintains Buy on Wave Life Sciences, Raises Price Target to $44

Benzinga Newsdesk 3 weeks ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Canaccord Genuity analyst Whitney Ijem maintains Wave Life Sciences (NASDAQ:WVE) with a Buy and raises the price target from $42 to $44.

Canaccord Genuity analyst Whitney Ijem maintains Wave Life Sciences (NASDAQ:WVE) with a Buy and raises the price target from $42 to $44.

Read at benzinga.com